Study of BEBT-908 in Subjects With Advanced Hematological Tumors

Clinical trial NCT06082596 · COMPLETED

Trial details

NCT number: NCT06082596
Sponsor: BeBetter Med Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Non-Hodgkin's Lymphoma Relapsed or Refractory Multiple Myeloma

Start date: 2016-03-02
Primary completion: 2019-03-08
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.